Biomab is a South African innovative pharmaceutical company established in 2020 to bring originator pharmaceutical products, new chemical entities and new biologicals into the South African market.
At Biomab, we are driven by our purpose to ensure faster and broader access to innovation for patients in Southern Africa. Through our unique, legal, and ethical solutions, we are committed to making a positive impact on healthcare. With a focus on originator and Biosimilar molecules, Biomab is at the forefront of revolutionizing patient access to life-changing medications.
Company Details
- Employees
- 8
- Founded
- 2020
- Address
- 3 Stirrup Lane, Woodmead Office Park, Woodmead,gauteng 2144,south Africa
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.biomab.co.za
- HQ
- Woodmead, Gauteng
Biomab Innovation Questions
Biomab Innovation's website is http://www.biomab.co.za
Biomab Innovation's LinkedIn profile is https://za.linkedin.com/company/biomab-innovation
Biomab Innovation has
8 employees.
View email and phone details for 8
employees at Biomab Innovation.
Biomab Innovation's industry is
Pharmaceutical Manufacturing
Biomab Innovation's top competitors are
Oncolab Diagnostics,
Jdj Diagnostics,
Biomab,
Biomab Inc.,
National Renal Care,
Eurolab,
Adcock Ingram,
Eurolab (Pty) Ltd.,
Pharmaceutical Manufacturing Technology Centre,
Patient Sentric.
Biomab Innovation's categories are Pharmaceutical Manufacturing
Biomab Innovation's founding year is 2020
